Sfoglia per AUTORE
CASADO A
Collezione AO Ordine Mauriziano

  

Items : 4

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer. in Gynecologic oncology / Gynecol Oncol. 2023 Jul;174:80-88. doi: 10.1016/j.ygyno.2023.04.028. Epub 2023 May 9.

2023
AO Ordine Mauriziano

Vergote I; Van Nieuwenhuysen E; Casado A; Laenen A; Lorusso D; Braicu EI; Guerra-Alia E; Zola P; Wimberger P; Debruyne PR; Falcó E; Ferrero A; Muallem MZ; Kerger J; García-Martinez E; Pignata S; Sehouli J; Van Gorp T; Gennigens C; Rubio MJ;

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. in Targeted oncology / Target Oncol. 2016 Jun;11(3):429. doi: 10.1007/s11523-016-0433-x.

2016
AO Ordine Mauriziano

Despierre E; Vergote I; Anderson R; Coens C; Katsaros D; Hirsch FR; Boeckx B; Varella-Garcia M; Ferrero A; Ray-Coquard I; Green JA; Steer C; Berns EM; Casado A; Lambrechts D; Jimeno A;

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. in Targeted oncology / Target Oncol. 2015 Dec;10(4):583-96. doi: 10.1007/s11523-015-0369-6.

2015
AO Ordine Mauriziano

Despierre E; Vergote I; Anderson R; Coens C; Katsaros D; Hirsch FR; Boeckx B; Varella-Garcia M; Ferrero A; Ray-Coquard I; Berns EM; Casado A; Lambrechts D; Jimeno A;

EORTC Gynecological Cancer Group on the frontline of practice-changing clinical trials in European Journal of Cancer, Supplement

2012
AO Ordine Mauriziano

Casado A; Penninckx B; Reed N; van der Burg MEL; Berns EMJJ; Katsaros D; Ferrero A; Mota F; Jimeno A; Vermorken J; Pecorelli S; Coens C; Vergote I;